Palmetto
Foundation Medicine, Natera Launch ctDNA Therapy Response Assay With Medicare Coverage
The tissue-informed ctDNA assay is available to US physicians and is eligible for coverage through both the MolDx and New York's CLEP programs.
Local Coverage Determinations Roundup: Scipher Medicine, Veracyte, Sonic Healthcare USA
A roundup of local coverage determinations from Medicare administrative contractors.
CareDx Eyes Wider Coverage, Adoption of Transplant Tests Despite Medicare Billing Article Impact
Premium
Adapting to the coverage decision put a dent in test volumes, but the firm has implemented needed changes and expects to see gains toward the end of the year.
The new policy would require test developers to obtain a Z-code through Palmetto GBA's registry for each individual assay it wants coverage for through United.
Local Coverage Determinations Roundup: Castle Biosciences
Multiple Medicare Administrative Contractors aligned their non-coverage decisions for Castle Biosciences' DecisionDx-SCC test.
Dec 8, 2022